automated-news
Bristol Myers Wins FDA Approval for Sotyktu for Psoriatic Arthritis
Bristol Myers won FDA approval for Sotyktu in active psoriatic arthritis, expanding its oral immunology franchise despite a slight after-hours stock dip. Read Full Article →